Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29499603 | 1.00 | CASP1 (0.34) | CASP1ALDH1A1MAPTMAPK1SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL5991120 | 0.98 | CASP1 (0.33) | CASP1ALDH1A1MAPTMAPK1SMN1; SMN2 | |
| SCHEMBL9999846 | 0.90 | ALDH1A1 (0.40) | CASP1ALDH1A1MAPTMAPK1PRKCI | |
| SCHEMBL2786924 | 0.85 | PRKCI (0.31) | CASP1PRKCIACHE | |
| SCHEMBL29353254 | 0.85 | PRKCI (0.31) | CASP1PRKCIACHE | |
| Ammonia Solution, Strong SCHEMBL5992940 | 0.83 | PRKCI (0.30) | PRKCI | |
| SCHEMBL10626050 | 0.81 | KMT2A (0.50) | ALDH1A1MAPTMAPK1SMN1; SMN2LMNA | |
| SCHEMBL8524523 | 0.81 | ADRA2B (0.31) | ALDH1A1MAPTMAPK1SMN1; SMN2LMNA | |
| SCHEMBL17047653 | 0.81 | PYCR1 (0.39) | ALDH1A1MAPTMAPK1SMN1; SMN2LMNA | |
| SCHEMBL26135328 | 0.80 | CASP1 (0.31) | CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1385823-B1 | GUANIDINO COMPOUNDS AS MELANOCORTIN-4 RECEPTOR (MC4-R) AGONISTS | CHIRON CORP (US) | 2006-12-13 | — | — | EP | claimed |
| US-20250257265-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| WO-2025127092-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025121249-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025121189-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025105279-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-05-22 | — | — | WO | disclosed |
| WO-2025105278-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-05-22 | — | — | WO | disclosed |
| US-20250145888-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL CORPORATION (JP) | 2025-05-08 | — | — | US | disclosed |
| WO-2025089307-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025079519-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-04-17 | — | — | WO | disclosed |
| US-20010039361-A1 | Materials for inducing alignment in liquid crystal and liquid crystal displays | GIBBONS WAYNE M (US) | 2001-11-08 | — | — | US | disclosed |
| US-6313348-B1 | LIQUID CRYSTAL | GIBBONS WAYNE M (US) | 2001-11-06 | — | — | US | disclosed |
| US-20010018099-A1 | Materials for inducing alignment in liquid crystals and liquid crystal displays | ELSICON, INC. | 2001-08-30 | — | — | US | disclosed |
| US-6268460-B1 | POLYIMIDES, POLYAMIC ACID AND ESTER COPOLYMERS | GIBBONS WAYNE M (US) | 2001-07-31 | — | — | US | disclosed |
| US-6242061-B1 | POLYAMIC ACIDS, POLYIMIDES | ELSICON INC. | 2001-06-05 | — | — | US | disclosed |
| WO-2001030938-A1 | MATERIALS FOR INDUCING ALIGNMENT IN LIQUID CRYSTALS AND LIQUID CRYSTAL DISPLAYS | ELSICON, INC. (US) | 2001-05-03 | — | — | WO | disclosed |
| US-6194039-B1 | POLYIMIDES, POLYAMIC ACIDS | ELSICON, INC. | 2001-02-27 | — | — | US | disclosed |
| US-6143380-A | POLYIMIDES | ELSICON INC. (US) | 2000-11-07 | — | — | US | disclosed |
| US-6103322-A | POLYAMIC ACID | ELSICON INC. (US) | 2000-08-15 | — | — | US | disclosed |
| WO-2000039633-A1 | MATERIALS FOR INDUCING ALIGNMENT OF LIQUID CRYSTALS AND LIQUID CRYSTAL OPTICAL ELEMENTS | ELSICON, INC. (US) | 2000-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039361-A1 | Materials for inducing alignment in liquid crystal and liquid crystal displays | DYNC1LI1, DYNC1LI2, DYNLL1 | CASP1 866/4885ALDH1A1 1492/4885MAPT 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.